RKDA

Arcadia Biosciences, Inc.

NasdaqCMUSDEQUITY DELAYED

0.44

▼ 0.01 (2.44%)

MARKET · —

Price

Open

0.45

Prev close

0.45

Day high

0.47

Day low

0.45

Volume

40.52K

Market cap

—

P/E (TTM)

—

52W range

0.38 – 6.71

Trailing performance

Price return · vs SPY

Returnvs SPY

-26.72% -25.4%

-26.37% -30.1%

-49.45% -52.5%

-75.77% -86.8%

YTD

-76.87% -89.2%

-89.54% -109.5%

-89.27% -163.4%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

0.55

-19.71% from price

SMA 20

0.60

-24.17% from price

SMA 50

0.68

-32.56% from price

SMA 100

0.89

-50.63% from price

SMA 200

1.74

-73.62% from price

EMA 12

0.54

-18.41% from price

EMA 26

0.60

-27.07% from price

EMA 50

0.70

-37.30% from price

RSI (14)

34.7

Neutral

MACD (12,26,9)

-0.06

Hist -0.02

ATR (14)

0.08

17.75% of price

Realised vol 30D

121.5%

Annualised

Bollinger upper

0.79

20, 2σ

Bollinger lower

0.42

20, 2σ

50 / 200 cross

Death

0.68 vs 1.74

Trend bias

Below 200

-73.62%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.08

More volatile than market

Correlation to SPY

0.13

Largely independent

Realised vol 30D

121.5%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-92.3%

Peak to trough

Max drawdown 5Y

-99.6%

Peak to trough

ATR 14

0.08

17.75% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 0.44

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

RKDA · links out to the publisher

Arcadia Biosciences: Q2 Earnings Snapshot Associated Press · 9d ago Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights GlobeNewswire · 9d ago Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules GlobeNewswire · 71d ago Arcadia Biosciences Raises $4 Million in Private Placement MT Newswires · 72d ago Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules GlobeNewswire · 72d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.